The use of FDG-PET/CT in patients with febrile neutropenia

Seminars in Nuclear Medicine

Volumn 43, Issue 5, 2013, Pages 340-348

  Vos, Fidel J ^a   Bleeker Rovers, Chantal P ^a   Oyen, Wim J G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18;

ABSCESS; ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; COLITIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CYTOTOXICITY; DIAGNOSTIC TEST ACCURACY STUDY; ESOPHAGITIS; FEBRILE NEUTROPENIA; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HUMAN; INDUCTION CHEMOTHERAPY; LUNG ASPERGILLOSIS; LUNG SMALL CELL CANCER; META ANALYSIS; METASTASIS; NEUTROPHIL; NEUTROPHIL COUNT; PREDICTIVE VALUE; PYREXIA IDIOPATHICA; RESPIRATORY TRACT INFECTION; SENSITIVITY AND SPECIFICITY; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; SYSTEMIC MYCOSIS; THROMBOPHLEBITIS;

ANTINEOPLASTIC AGENTS; FEBRILE NEUTROPENIA; FLUORODEOXYGLUCOSE F18; HUMANS; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84881117373     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2013.04.007     Document Type: Article

References (49)

1. P.A. Pizzo Management of fever in patients with cancer and treatment-induced neutropenia N Engl J Med 328 1993 1323 1332
2. J. Crawford, D.C. Dale, and G.H. Lyman Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management Cancer 100 2004 228 237
3. J.N. Timmer-Bonte, T.M. de Boo, and H.J. Smit Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: A Dutch Randomized Phase III Study J Clin Oncol 23 2005 7974 7984
4. H. Gómez, M. Hidalgo, and L. Casanova Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: Results of a multivariate analysis J Clin Oncol 16 1998 2065 2069
5. J.Y. Blay, F. Chauvin, and A. Le Cesne Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia J Clin Oncol 14 1996 636 643
6. J.H. Silber, M. Fridman, and R.S. DiPaola First-cycle blood counts and subsequent neutropenia, dose reduction, or delay in early-stage breast cancer therapy J. Clin Oncol 16 1998 2392 2400
7. G.H. Lyman, C.H. Lyman, and O. Agboola Risk models for predicting chemotherapy-induced neutropenia Oncologist 10 2005 427 437
8. N.M.A. Blijlevens, J.P. Donnelly, and B.E. De Pauw Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant Bone Marrow Transplant 35 2005 707 711
9. C.P. Bleeker-Rovers, F.J. Vos, and W.T. van der Graaf Nuclear medicine imaging of infection in cancer patients (with emphasis on FDG-PET) Oncologist 16 2011 980 991
10. S.C. Schimpff Empiric antibiotic therapy for granulocytopenic cancer patients Am J Med 80 1986 13 20
11. W.T. Hughes, D. Armstrong, and G.P. Bodey 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis 34 2002 730 751
12. S.N. O'Brien, N.M. Blijlevens, and T.H. Mahfouz Infections in patients with hematological cancer: Recent developments Hematology Am Soc Hematol Educ Program 2003 438 472
13. D.A. Koolen, H.W. van Laarhoven, and T. Wobbes Single-centre experience with tunnelled central venous catheters in 150 cancer patients Neth J Med 60 2002 397 401
14. W.J. van der Velden, N.M. Blijlevens, and T. Feuth Febrile mucositis in haematopoietic SCT recipients Bone Marrow Transplant 43 2009 55 60
15. M. Nucci, and E. Anaissie Revisiting the source of candidemia: Skin or gut? Clin Infect Dis 33 2001 1959 1967
16. G.P. Bodey, M. Buckley, and Y.S. Sathe Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia Ann Intern Med 64 1966 328 340
17. C.P. Bleeker-Rovers, E.M. de Kleijn, and F.H. Corstens Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation Eur J Nucl Med Mol Imaging 31 2004 29 37
18. C. Cordonnier, A. Buzyn, and G. Leverger Epidemiology and risk factors for gram-positive coccal infections in neutropenia: Toward a more targeted antibiotic strategy Clin Infect Dis 36 2003 149 158
19. L.J. Walshe, S.F. Malak, and J. Eagan Complication rates among cancer patients with peripherally inserted central catheters J Clin Oncol 20 2002 3276 3281
20. H.F. Kennedy, D. Morrison, and M.E. Kaufmann Origins of Staphylococcus epidermidis and Streptococcus oralis causing bacteraemia in a bone marrow transplant patient J Med Microbiol 49 2000 367 370
21. M. Miceli, R. Atoui, and R. Walker Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: A preliminary report J Clin Oncol 22 2004 1949 1956
22. J. Klastersky Antifungal therapy in patients with fever and neutropenia - more rational and less empirical? N Engl J Med 351 2004 1445 1447
23. D.J. Winston, J.W. Hathorn, and M.G. Schuster A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer Am J Med 108 2000 282 289
24. D. Caillot, O. Casasnovas, and A. Bernard Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery J Clin Oncol 15 1997 139 147
25. S. Doron, and L.E. Davidson Antimicrobial stewardship Mayo Clin Proc 86 2011 1113 1123
26. M. Paul, D. Yahav, and A. Fraser Empirical antibiotic monotherapy for febrile neutropenia: Systematic review and meta-analysis of randomized controlled trials J Antimicrob Chemother 57 2006 176 189
27. P.E. Verweij, J.P. Donnelly, and C.E. van Die Improved diagnostics in invasive aspergillosis and systematic monitoring in patients at high risk of infection Ned Tijdschr Geneeskd 149 2005 561 567
28. C.A. Ohl, and E.S. Dodds Ashley Antimicrobial stewardship programs in community hospitals: The evidence base and case studies Clin Infect Dis 53 2011 S23 S28
29. J.E. Kuhlman, E.K. Fishman, and S.S. Siegelman Invasive pulmonary aspergillosis in acute leukemia: Characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis Radiology 157 1985 611 614
30. D.P. Orr, R.L. Myerowitz, and P.J. Dubois Patho-radiologic correlation of invasive pulmonary aspergillosis in the compromised host Cancer 41 1978 2028 2039
31. U. Blum, M. Windfuhr, and C. Buitrago-Tellez Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis Chest 106 1994 1156 1161
32. D. Blockmans, D. Knockaert, and A. Maes Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin Clin Infect Dis 15 32 2001 191 196
33. 18F-FDG PET in detecting metastatic infectious disease J Nucl Med 46 2005 2014 2019
34. 18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation Eur J Nucl Med Mol Imaging 39 2012 120 128
35. 18F- fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: A study of 165 infectious episodes J Clin Oncol 23 2005 7857 7863
36. S.D. Guy, A.R. Tramontana, and L.J. Worth Use of FDG PET/CT for investigation of febrile neutropenia: Evaluation in high-risk cancer patients Eur J Nucl Med Mol Imaging 39 2012 1348 1355
37. K.C. Koh, M.A. Slavin, and K.A. Thursky Impact of fluorine-18 fluorodeoxyglucose positron emission tomography on diagnosis and antimicrobial utilization in patients with high-risk febrile neutropenia Leuk Lymphoma 53 2012 1889 1895
38. 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections Med Mycol 46 2008 23 29
39. A.E. Müller, R. Kluge, and M. Biesold Whole body positron emission tomography detected occult infectious foci in a child with acute myeloid leukaemia Med Pediatr Oncol 38 2002 58 59
40. M. Wilkinson, M. Fulham, and B. MC Caughan Invasive aspergillosis mimicking stage IIIA non-small-cell lung cancer on FDG positron emission tomography Clin Nuc Med 28 2003 234 235
41. Y. Miyazaki, Y. Nawa, and K. Nakase FDG-PET can evaluate the treatment for fungal liver abscess much earlier than other imagings Ann Hematol 90 2011 1489 1490
42. A.Y. Ho, A. Pagliuca, and M.N. Maisey Positron emission scanning with 18-FDG in the diagnosis of deep fungal infections Br J Haematol 101 1998 392 393
43. B. Xu, P. Shi, and H. Wu Utility of FDG PET/CT in guiding antifungal therapy in acute leukemia patients with chronic disseminated candidiasis Clin Nucl Med 35 2010 567 570
44. 18F]fluorodeoxyglucose for invasive fungal infections Clin Microbiol Infect 17 2011 409 417
45. N.M. Blijlevens, L.C. Lutgens, and A.V. Schattenberg Citrulline: A potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy Bone Marrow Transplant 34 2004 193 196
46. N.M. Blijlevens, J.P. Donnelly, and B.E. De Pauw Mucosal barrier injury: Biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: An overview Bone Marrow Transplant 25 2000 1269 1278
47. B. Vahid, B. Wildemore, and C. Nguyen Pulmonary blastomycosis masquerading as metastatic disease in the lung: A case report Med Gen Med 8 2006 31
48. R. Kubota, S. Yamada, and K. Kubota Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography J Nucl Med 33 1992 1972 1980
49. R.S. Brown, J.Y. Leung, and S.J. Fisher Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med 36 1995 1854 1861